CD109 promotes drug resistance in A2780 ovarian cancer cells by regulating the STAT3-NOTCH1 signaling axis
JS Kim, MJ Shin, SY Lee, DK Kim, KU Choi… - International Journal of …, 2023 - mdpi.com
Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy owing to
relapse caused by resistance to chemotherapy. We previously reported that cluster of …
relapse caused by resistance to chemotherapy. We previously reported that cluster of …
[HTML][HTML] CD109 drives pro-tumorigenic cell properties in human non-small cell lung cancer through interaction with desmoglein-2
W Lückstädt, M Rathod, L Möbus, S Bub… - Research …, 2024 - ncbi.nlm.nih.gov
Abstract Cluster of differentiation 109 (CD109) is a glycosylphosphatidylinositol (GPI)
anchored cell surface protein, expressed on epithelial and endothelial cells, CD4+ and …
anchored cell surface protein, expressed on epithelial and endothelial cells, CD4+ and …
The Co-expression of HER Family Members and CD109 is common in Pancreatic Cancer.
T Khan, AM Seddon, SA Khelwatty… - Medical Research …, 2023 - esmed.org
In the absence of biomarkers for the early detection of pancreatic cancer and the
development of more effective therapeutic interventions, pancreatic cancer is projected to …
development of more effective therapeutic interventions, pancreatic cancer is projected to …
Prognostic significance, predictive value, and targeting of the HER-family members in pancreatic cancer
T Khan - 2023 - eprints.kingston.ac.uk
Pancreatic cancer is one of the most aggressive, heterogeneous, and deadliest types of
human cancer. In the past few decades, aberrant expression and activation of human …
human cancer. In the past few decades, aberrant expression and activation of human …